As the coronavirus rages around the world, Pfizer Inc. and BioNTech SE face a major challenge in delivering its vaccine. The vaccine needs to be kept in ultra-cold storage at around minus-94 degrees Fahrenheit (minus-70 Celsius). To accomplish this, the companies have developed a shipping container packed with dry ice that will maintain the temperature during transit. Administration sites with freezers can store the vaccines for six months; sites without freezers can keep vials in the shipping boxes for up to 15 days if the dry ice is replenished.
--With assistance from
To ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
